According to Neogen's latest financial reports and stock price the company's current Operating Margin is -56.10%. At the end of 2024 the company had an Operating Margin of -1.55%.
Year | Operating Margin | Change |
---|---|---|
2024 | -1.55% | -42.25% |
2023 | -2.68% | -123.47% |
2022 | 11.42% | -28.92% |
2021 | 16.07% | -7.08% |
2020 | 17.29% | -1.84% |
2019 | 17.62% | -4.59% |
2018 | 18.46% | -0.79% |
2017 | 18.61% | 7.7% |
2016 | 17.28% | -6.08% |
2015 | 18.40% | 5.77% |
2014 | 17.39% | -12.26% |
2013 | 19.82% | 7.82% |
2012 | 18.39% | -9.79% |
2011 | 20.38% | 4.82% |
2010 | 19.44% | 6.75% |
2009 | 18.21% | 0.85% |
2008 | 18.06% | 12.13% |
2007 | 16.11% | -3.5% |
2006 | 16.69% | 17.49% |
2005 | 14.21% | 2.75% |
2004 | 13.83% | -9.34% |
2003 | 15.25% | 5.17% |
2002 | 14.50% | 3.91% |
2001 | 13.96% |
Company | Operating Margin | Operating Margin differencediff. | Country |
---|---|---|---|
![]() PerkinElmer
PKI | 14.13% | -125.19% | ๐บ๐ธ USA |
![]() IDEXX Laboratories IDXX | 28.47% | -150.75% | ๐บ๐ธ USA |
![]() Illumina ILMN | -26.96% | -51.94% | ๐บ๐ธ USA |
![]() Pacific Biosciences
PACB | -431.70% | 669.52% | ๐บ๐ธ USA |
![]() Meridian Bioscience VIVO | 16.31% | -129.07% | ๐บ๐ธ USA |
![]() Thermo Fisher Scientific TMO | 16.47% | -129.36% | ๐บ๐ธ USA |
![]() Danaher DHR | 19.45% | -134.67% | ๐บ๐ธ USA |
![]() Becton Dickinson BDX | 8.06% | -114.37% | ๐บ๐ธ USA |
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.